LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | JW-7-24-1 | 0.12 | uM | LJP6 | 1 | B23 | 72 | hr | 1657 | 4887 | 5505 | 0.8876 | 0.8392 |
BT-20 | JW-7-24-1 | 0.12 | uM | LJP6 | 2 | B23 | 72 | hr | 1657 | 5209 | 5505 | 0.9461 | 0.9229 |
BT-20 | JW-7-24-1 | 0.12 | uM | LJP6 | 3 | B23 | 72 | hr | 1657 | 5487 | 5505 | 0.9966 | 0.9952 |
BT-20 | Lapatinib | 0.12 | uM | LJP6 | 1 | M23 | 72 | hr | 1657 | 5087 | 5505 | 0.9240 | 0.8912 |
BT-20 | Lapatinib | 0.12 | uM | LJP6 | 2 | M23 | 72 | hr | 1657 | 5107 | 5505 | 0.9276 | 0.8964 |
BT-20 | Lapatinib | 0.12 | uM | LJP6 | 3 | M23 | 72 | hr | 1657 | 5592 | 5505 | 1.0157 | 1.0224 |
BT-20 | LDN-193189 | 0.12 | uM | LJP5 | 1 | G05 | 72 | hr | 1657 | 5158 | 5505 | 0.9369 | 0.9097 |
BT-20 | LDN-193189 | 0.12 | uM | LJP5 | 2 | G05 | 72 | hr | 1657 | 5278 | 5505 | 0.9587 | 0.9408 |
BT-20 | LDN-193189 | 0.12 | uM | LJP5 | 3 | G05 | 72 | hr | 1657 | 5061 | 5505 | 0.9192 | 0.8844 |
BT-20 | Linifanib | 0.12 | uM | LJP6 | 1 | J11 | 72 | hr | 1657 | 5958 | 5505 | 1.0822 | 1.1176 |
BT-20 | Linifanib | 0.12 | uM | LJP6 | 2 | J11 | 72 | hr | 1657 | 5549 | 5505 | 1.0079 | 1.0113 |
BT-20 | Linifanib | 0.12 | uM | LJP6 | 3 | J11 | 72 | hr | 1657 | 5784 | 5505 | 1.0506 | 1.0723 |
BT-20 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 1657 | 4872 | 5505 | 0.8849 | 0.8353 |
BT-20 | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 1657 | 5075 | 5505 | 0.9218 | 0.8881 |
BT-20 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 1657 | 4920 | 5505 | 0.8936 | 0.8478 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP5 | 1 | C23 | 72 | hr | 1657 | 2154 | 5505 | 0.3912 | 0.1290 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP5 | 2 | C23 | 72 | hr | 1657 | 1903 | 5505 | 0.3456 | 0.0637 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP5 | 3 | C23 | 72 | hr | 1657 | 2040 | 5505 | 0.3705 | 0.0993 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP6 | 1 | C23 | 72 | hr | 1657 | 2124 | 5505 | 0.3858 | 0.1212 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP6 | 2 | C23 | 72 | hr | 1657 | 1912 | 5505 | 0.3473 | 0.0661 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP6 | 3 | C23 | 72 | hr | 1657 | 2113 | 5505 | 0.3838 | 0.1183 |
BT-20 | MK2206 | 0.12 | uM | LJP6 | 1 | F05 | 72 | hr | 1657 | 5006 | 5505 | 0.9093 | 0.8702 |
BT-20 | MK2206 | 0.12 | uM | LJP6 | 2 | F05 | 72 | hr | 1657 | 5174 | 5505 | 0.9398 | 0.9138 |
BT-20 | MK2206 | 0.12 | uM | LJP6 | 3 | F05 | 72 | hr | 1657 | 4908 | 5505 | 0.8915 | 0.8447 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 1657 | 4366 | 5505 | 0.7930 | 0.7038 |